ValuationViz

LGND fund manager activity

Ligand Pharmaceuticals Incorporated · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q3 2013 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded130,858$24,741,3210.01%Feb 9, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed9,346$1,767,0480.01%Feb 17, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementAdded108,926$19,295,1500.01%Nov 12, 2025
Joel Greenblatt - Gotham Asset ManagementNew9,475$1,678,4020.01%Nov 14, 2025
Tweedy BrowneSold out——0.00%Nov 20, 2025

Newer quarters · Older quarters